Related Experiment Video
Updated: Aug 8, 2026
High Sensitivity Measurement of Transcription Factor-DNA Binding Affinities by Competitive Titration Using Fluorescence Microscopy
Published on: February 7, 2019
Binding of MAR-DNA elements by mutant p53: possible implications for its oncogenic functions
1Heinrich-Pette-Institut für Experimentelle Virologie und Immunologie, Hamburg, Germany.
Abstract:
The tumor suppressor p53 is a multifunctional protein whose main duty is to preserve the integrity of the genome. This function of wild-type p53 as "guardian of the genome" is achieved at different levels, as a cell cycle checkpoint protein, halting the cell cycle upon DNA damage, and via a direct involvement in processes of DNA repair. Alternatively, p53 can induce apoptosis. Mutations in the p53 gene occur in about 50% of all human tumors and eliminate the tumor suppressor functions of p53. However, many mutant p53 proteins have not simply lost tumor suppressor functions but have gained oncogenic properties which contribute to the progression of tumor cells to a more malignant phenotype. The molecular basis for this gain of function of mutant p53 is still unknown. However, mutant (mut) p53 specifically binds to nuclear matrix attachment region (MAR) DNA elements. MAR elements constitute important higher order regulatory elements of chromatin structure and function. By binding to these elements, mut p53 could modulate important cellular processes, like gene expression, replication, and recombination, resulting in phenotypic alterations of the tumor cells. Mut p53 thus could be the first representative of a new class of oncogenes, which exert their functions via long-range alterations or perturbation of chromatin structure and function.
Insights
Mutant p53 proteins gain oncogenic properties, unlike wild-type p53 which guards the genome. Mutant p53 binds to DNA elements, potentially driving tumor progression by altering chromatin structure.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- The p53 protein acts as a tumor suppressor, maintaining genome integrity by controlling cell cycle checkpoints and DNA repair.
- Mutations in the p53 gene are common in human tumors, often leading to loss of tumor suppressor functions.
- Some p53 mutations result in a 'gain of function,' where mutant p53 actively promotes tumor progression and malignancy.
Purpose of the Study:
- To investigate the molecular mechanisms behind the oncogenic gain of function observed in mutant p53 proteins.
- To explore the potential role of mutant p53 binding to specific DNA elements in altering cellular processes and promoting cancer phenotypes.
Main Methods:
- Analysis of mutant p53 protein interactions with DNA.
- Investigation of the role of nuclear matrix attachment region (MAR) DNA elements in mediating mutant p53 functions.
- Assessment of the impact of MAR binding by mutant p53 on gene expression, replication, and recombination.
Main Results:
- Mutant p53 proteins exhibit specific binding to nuclear matrix attachment region (MAR) DNA elements.
- MAR elements are crucial for higher-order chromatin structure and function.
- Mutant p53 binding to MAR elements may modulate critical cellular processes, leading to altered tumor cell phenotypes.
Conclusions:
- Mutant p53 gains oncogenic functions beyond the loss of its tumor suppressor role.
- The specific binding of mutant p53 to MAR DNA elements is a key mechanism for its oncogenic activity.
- Mutant p53 may represent a novel class of oncogenes that function by altering chromatin structure and function.
Related Concept Videos
01:23Negative Regulator Molecules
02:04Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
02:36DNA Damage can Stall the Cell Cycle
02:23Abnormal Proliferation
01:19Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
02:36DNA Damage Can Stall the Cell Cycle